Ingenix
Latest round
- Seed
Last raised
- Jun 2026
Total raised
- $25M
Investors
- 4
About Ingenix
o.o. was founded in 2023 in Warsaw, Poland, focusing on AI-powered clinical trial simulations. The company was founded by individuals whose specific identities are not publicly detailed, and there are no mentions of previous companies established by them. Ingenix offers a proprietary multimodal and multiscale generative AI platform designed specifically for clinical development. The core product, Ingenix, functions as a co-pilot for simulating clinical trials using advanced chain-of-thought prompting techniques. It integrates diverse biological and medical knowledge through various modalities, including text, graphics, bioimaging, and 3D structures. The platform aims to address the complexities of drug development by providing granular predictions of clinical endpoint values and adverse events, enabling clinical investigators to optimize drug candidate selection and make informed decisions. Ingenix serves a range of stakeholders across the pharmaceutical industry, including pre-clinical development teams, strategy teams, and clinical development teams, primarily focusing on markets in North America and Europe. Ingenix generates revenue through partnerships with pharmaceutical companies and clinical research organizations, offering subscription-based access to its AI platform. Transaction structures typically involve B2B agreements where clients pay for access to the platform on an annual or project basis, depending on the scope of their research needs. The platform's flagship service allows clients to leverage its advanced predictive capabilities for drug development, thereby streamlining their research processes. Specific pricing plans for the service are determined based on the scale of usage and the complexity of the services required, aligning with the unique needs of each client. By facilitating data-driven insights, Ingenix positions itself as an essential tool in the burgeoning field of AI-assisted drug discovery.o.
Who invested in Ingenix
4 investors across 2 rounds
See all investors in Ingenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ingenix
Who invested in Ingenix?
Ingenix has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ingenix raised?
Ingenix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ingenix last raise money?
Ingenix's most recent round on record is a Seed, in Jun 2026.
What does Ingenix do?
Ingenix is a biotechnology company.
Where is Ingenix headquartered?
Ingenix is headquartered in Warsaw, Poland.
Which VCs invest in companies like Ingenix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Ingenix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ingenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.